MARKET

IMMP

IMMP

Immutep
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.730
-0.090
-4.95%
Closed 16:00 11/14 EST
OPEN
1.800
PREV CLOSE
1.820
HIGH
1.800
LOW
1.620
VOLUME
76.41K
TURNOVER
--
52 WEEK HIGH
3.230
52 WEEK LOW
1.270
MARKET CAP
6.28M
P/E (TTM)
-0.4395
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IMMP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IMMP News

  • Immutep Reports European Patent Grant For LAG525 Antibody
  • Benzinga.14h ago
  • Immutep Announces European Patent Grant for LAG525 Antibody
  • GlobeNewswire.14h ago
  • The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
  • Benzinga.6d ago
  • Immutep Reports Interim Data From Phase 2 TACTI-002 Trial At SITC
  • Benzinga.6d ago

More

Industry

Biotechnology & Medical Research
-0.05%
Pharmaceuticals & Medical Research
-0.27%

Hot Stocks

Name
Price
%Change

About IMMP

Immutep Ltd, formerly Prima BioMed Ltd., is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment. Its core technologies are based on the Lymphocyte-activation gene 3 (LAG-3) immune control mechanism, which is involved in regulation of the T cell immune response. Its product, IMP321, is in clinical development for the treatment of a range of cancer indications, such as Metastatic Breast Cancer. IMP321 is in Phase IIb trials for Metastatic Breast Cancer and is being studied in Phase I for the treatment of Metastatic Melanoma. The Company is also focused on development of other products, which include IMP701, an antibody for cancer, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer.
More

Webull offers Immutep Ltd (IMMP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.